Popular Diet Drugs Pulled From Market

Primary Pulmonary
Hypertension (PPH)

Causes of PAH/PPH

PAH/PPH Symptoms
& Diagnosis

Pictures of PAH/PPH

PAH/PPH Treatment Options

• Drugs & Transplantation

• PAH/PPH Doctors

• PAH/PPH Clinics

• Questions For the Doctor

• Coping With PAH/PPH

Financial Aid For Patients

PAH/PPH News

Site Map

Search for information:

Click Here for a Free
Information Packet

FOR MORE INFORMATION
Please call
1-800-923-6376

We will gladly answer your questions and send a free packet with additional
information on:

New treatment options
New clinical trials
Doctors
Hazardous jobs and products
Financial Assistance

Primary Arterial Hypertension

(Primary Pulmonary Hypertension)

Primary Arterial Hypertension News - Menu

2 popular diet drugs pulled from market

Fen-phen, Redux linked to heart risk

September 15 - PHILADELPHIA (CNN) -- Two of the most popular diet drugs on the U.S. market were recalled Monday after being linked to serious heart damage.

The recall was for Redux, known chemically as dexfenfluramine, and Pondimin, also known as fenfluramine. Fenfluramine is half of the popular diet drug combination called fen-phen. The other half, phentermine, is not affected by the recall, but patients should no longer use the combination.

"If individuals are taking these medications, they should cease taking them and should consult with their physicians about what next steps should be taken," said Dr. Michael Friedman, acting head of the Food and Drug Administration.
Redux

The FDA said new preliminary data showed that doctors had observed heart lesions in 30 percent of patients using the drugs.

The FDA said that many of the patients with the lesions were not having immediate health problems, but that others suffered from shortness of breath, chest pain, fainting, swelling of the ankles and heart murmurs.

Wyeth-Ayerst, the maker of Pondimin and marketer of Redux, withdrew the drugs at the request of the FDA, and the maker of Redux, Interneuron Pharmaceuticals, also agreed to pulling the products.

Wyeth-Ayrst said it planned to place full-page notices in newspapers nationwide announcing the withdrawal. Patients were advised to call a toll-free number, (800) 892-2718, if they had any questions.

FREE
PAH/PPH Patient
Info Packet

Click here today,
and get this free patient information packet sent to you quickly.

Popular Searches
fen phen
pah symptoms
heart attack
hypertension

To Obtain the Best Treatment Info & Financial Assistance contact us for a free PAH/PPH information packet which includes:

Hospital Locations
Clinical Trials
Hazardous Jobs/ Products

New Treatment Options
Doctors
Financial Assistance

Fill out the form below or call 1-800-923-6376.

First Name
Last Name
Address
City
State
Zip
Phone
Email

Have you or a loved one been diagnosed or have:

Pulmonary Hypertension?			Yes No
Primary Pulmonary Hypertension (PPH)?			Yes No
Pulmonary Arterial Hypertension (PAH)?			Yes No
Persistent Pulmonary Hypertension Newborn?			Yes No
Have you had a Valve Replacement?			Yes No
Are you on a treatment such as Flolan, Tracleer, Remodulin, Rivatio (Viagra), Ventavis, or other?			Yes No
Did you or your loved one take Fen Phen or other Diet Drugs?			Yes No
Did Mom take any antidepressant while pregnant resulting in a child with a diagnosis of Persistent Pulmonary Hypertension Newborn?			Yes No

Comment / Info Request